Rational hemostatic screening;Rationelles hamostase-screening

Medizinische Klinik

Volumn 94, Issue 3, 1999, Pages 165-169

  Maurin, Norbert ^a  

^a Chefarzt der Medizinischen Klinik   (Germany)

Author keywords

Bleeding time; Graded diagnostic approach; Hemorrhagic diathesis; Hemostatic screening; Prothrombin time; Pseudothrombocytopenia; Rumpel Leede test

Indexed keywords

ALPHA 2 ANTIPLASMIN; BLOOD CLOTTING FACTOR 8; FIBRINOGEN;

ALGORITHM; ANAMNESIS; ARTICLE; BLEEDING TENDENCY; BLEEDING TIME; BLOOD CLOTTING PARAMETERS; CAPILLARY RESISTANCE; CLINICAL EXAMINATION; HEMOSTASIS; HUMAN; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; SCREENING; BLEEDING DISORDER; BLOOD; BLOOD CLOTTING TEST; DIAGNOSTIC TEST; PHYSICAL EXAMINATION; PHYSIOLOGY; REVIEW;

BLOOD COAGULATION TESTS; DIAGNOSTIC TESTS, ROUTINE; HEMORRHAGIC DISORDERS; HEMOSTASIS; HUMANS; PHYSICAL EXAMINATION;

EID: 0033558919     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03044847     Document Type: Article

References (34)

1. Babson SR, Babson AL. Development and evaluation of a disposable device for performing simultaneous duplicate bleeding time determinations. Am J Clin Pathol 1978;70:406-8.
2. Bachmann F. Diagnostic approach to mild bleeding disorders. Semin Hematol 1980;17:292-305.
3. Barber A, Green P, Cralluto T, et al. The bleeding time as a preoperative screening test. Am J Med 1985;78:761-4.
4. Barthels M, Poliwoda H. Gerinnungsanalysen, 4. Aufl. Stuttgart-New York: Thieme, 1993.
5. Bowie EJW, Owen CA. The significance of abnormal preoperative hemostatic tests. Prog Hemost Thromb 1980;5:179-209.
6. Burns ER, Lawrence C. Bleeding time: a guide to its diagnostic and clinical utility. Arch Pathol Lab Med 1989;113:1219-24.
7. Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol 1957;17:237-46.
8. Colon-Otero G, Cockerill KJ, Bowie EJW. How to diagnose bleeding disorders. Postgrad Med 1991;90:145-50.
9. Duke WW. The relation of blood platelets to hemorrhagic disease. Description of a method for determining the bleeding time and coagulation time and report of three cases of hemorrhagic disease relieved by transfusion. JAMA 1910;55:1185-92.
10. Harker LA, Slichter SJ. The bleeding time as a screening test for evaluation of platelet function. N Engl J Med 1972;287:155-9.
11. Hellem AJ, Borchgrevink CF, Ames SB. The role of red cells in haemostasis: the relation between haematocrit, bleeding time and platelet adhesiveness. Br J Haematol 1961;7:42-50.
12. Ivy AC, Nelson D, Bucher G. The standardization of certain factors in the cutaneous "venostasis" bleeding time technique. J Lab Clin Med 1941;26:1812-22.
13. Ivy AC, Shapiro PF, Melnick P. The bleeding tendency in jaundice. Surg Gynecol Obstet 1935;60:781-3.
14. Kratzer MAA, Born GVR. Simulation of primary haemostasis vitro. Haemostasis 1985;15:357-62.
15. Kumar R, Ansell JE, Canoso RT, et al. Clinical trial of a new bleeding-time device. Am J Clin Pathol 1978;70:642-5.
16. Kundu SK, Heilmann EJ, Sio R, et al. Description of an in vitro platelet function analyzer - PFA-100TM. Semin Thromb Hemost 1995;21:Suppl 2:106-12.
17. Lechner K. Stufendiagnostik hämorrhagischer Diathesen. Internist (Berlin) 1985;26:141-6.
18. Leede C, Hautblutungen durch Stauung hervorgerufen als diagnostisches Hilfsmittel beim Scharlach. Münch Med Wochenschr 1911;58:293-5.
19. Lind SE. The bleeding time does not predict surgical bleeding. Blood 1991;77:2547-52.
20. Mammen EF, Alshameeri RS, Comp PC. Preliminary data from a field trial of the PFA-100TM system. Semin Thromb Hemost 1995;21:Suppl 2:113-21.
21. Mant MJ, Doery JCG, Gauldie J, et al. Pseudothrombocytopenia due to platelet aggregation and degranulation in blood collected in EDTA. Scand J Haematol 1975;15:161-70.
22. Mielke CH, Kaneshiro MM, Rapaport SI. The standardized normal Ivy bleeding time and its prolongation by aspirin. Blood 1969;34:204-15.
23. Oette K. Pers. Mitt., 1997.
24. Proctor RR, Rapaport SI. The partial thromboplastin time with kaolin: a simple screening test for first stage plasma clotting factor deficiencies. Am J Clin Pathol 1961;36:212-9.
25. Quick AJ. Salicylates and bleeding: the aspirin tolerance test. Am J Med Sci 1996;252:265-9.
26. Quick AJ, Stanley-Brown M, Bancroft FW. A study of the coagulation defect in hemophilia and in jaundice. Am J Med Sci 1935;190:501-11.
27. Rapaport SI. Preoperative hemostatic evaluation: which tests, if any? Blood 1983;61:229-31.
28. Rodgers RPC. A critical reappraisal of the bleeding time. Semin Thromb Hemost 1990;16:1-20.
29. Rosenkranz B, Wisser H, Bode JC. Pseudothrombopenie - eine Störung der Thrombozytenzahlbestimmung. Dtsch Med Wochenschr 1985;110:492-5.
30. Schneider W, Winkelmann M. Pseudothrombozytopenie und Immunthrombozytopenie. Med Welt 1986;37:1249-56.
31. Schwick HG. Therapie und Diagnostik von Blutgerinnung und Fibrinolyse - Rückblick und Ausblick. In: Mammen EF, Hrsg. Intensivmedizin aktuell. Marburg: Medizinische Verlagsgesellschaft, 1987:146-51.
32. Stuart MJ, Miller ML, Davey FR, et al. The post-aspirin bleeding time: a screening test for evaluating haemostatic disorders. Br J Haematol 1979;43:649-59.
33. WHO Expert Committee on Biological Standardization. Thirty-third Report: Technical Report Series 687. Geneva: WHO, 1983:81-105.
34. 2-antiplasmin activity. Arch Intern Med 1989;149:1769-72.